Clinical Trial Update: Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™) [Phase 4]

View source ↗

Summary

Phase 4 study evaluating intraoperative imaging of gastrointestinal cancers using pafolacianine (CYTALUX); recruitment is ongoing. The sponsor is Cedars-Sinai M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendiceal Cancer
• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Cytalux (pafolacianine)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Gastrointestinal Cancer, Gastric Cancer | Phase 4 | Status: RECRUITING